PATENT CLAIM ANALYSIS

Application Number: 16098260
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["424", "133100"]

Abstract:
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

Claim (Index 9):
The compound of  claim 1 , wherein n is 2.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 98.0
- Lexical Diversity: 1.24324
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16098288', '16098239', '14933879', '15422118', '16098257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7448932510549936
- 35 USC 102 Novelty (BERT): 0.540799684606315
- Combined Prediction Score: 0.7244838944101257
- Mean Citation Score: 347.293898
- Max Citation Score: 369.6778
- Similarity Product: 341.878197854197

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test